Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof

US9345741B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9345741-B2
Application numberUS-201313833039-A
CountryUS
Kind codeB2
Filing dateMar 15, 2013
Priority dateMar 15, 2013
Publication dateMay 24, 2016
Grant dateMay 24, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to nutritional compositions including a protein equivalent source that includes a peptide component comprising selected peptides. The protein equivalent source may further include intact protein, hydrolyzed protein, including partially hydrolyzed protein, or combinations thereof. The disclosure further relates to methods of promoting healthy body weight in a target subject by stimulating adiponectin levels by providing the nutritional compositions disclosed herein to a target subject, which includes a pediatric subject.

First claim

Opening claim text (preview).

What is claimed is: 1. A nutritional composition comprising: (i) a carbohydrate; (ii) a fat; and (iii) a protein equivalent, wherein (a) at least 20% of the protein equivalent includes a casein hydrolysate having a molar mass distribution of greater than 500 Daltons, and (b) at least 20% to 80% of the protein equivalent comprises a peptide component, wherein the peptide component consists of the following individual peptides: SEQ ID NO 4, SEQ ID NO 13, SEQ ID NO 17, SEQ ID NO 21, SEQ ID NO 24, SEQ ID NO 30, SEQ ID NO 31, SEQ ID NO 32, SEQ ID NO 51, SEQ ID NO 57, SEQ ID NO 60, and SEQ ID NO 63; further wherein the peptide component is present in amount of from about 0.2 g/100 kcals to about 5.6 g/100 kcals of the nutritional composition. 2. The nutritional composition of claim 1 , wherein the peptide component further comprises at least 10 individual peptides selected from the group consisting of SEQ ID NO 1, SEQ ID NO 2, SEQ ID NO 3, SEQ ID NO 5, SEQ ID NO 6, SEQ ID NO 7, SEQ ID NO 8, SEQ ID NO 9, SEQ ID NO 10, SEQ ID NO 11, SEQ ID NO 12, SEQ ID NO 14, SEQ ID NO 15, SEQ ID NO 16, SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 20, SEQ ID NO 22, SEQ ID NO 23, SEQ ID NO 25, SEQ ID NO 26, SEQ ID NO 27, SEQ ID NO 28, SEQ ID NO 29, SEQ ID NO 33, SEQ ID NO 34, SEQ ID NO 35, SEQ ID NO 36, SEQ ID NO 37, SEQ ID NO 38, SEQ ID NO 39, SEQ ID NO 40, SEQ ID NO 41, SEQ ID NO 42, SEQ ID NO 43, SEQ ID NO 44, SEQ ID NO 45, SEQ ID NO 46, SEQ ID NO 47, SEQ ID NO 48, SEQ ID NO 49, SEQ ID NO 50, SEQ ID NO 52, SEQ ID NO 53, SEQ ID NO 54, SEQ ID NO 55, SEQ ID NO 56, SEQ ID NO 58, SEQ ID NO 59, SEQ ID NO 61, SEQ ID NO 62, and SEQ ID NO 64. 3. The nutritional composition of claim 1 , wherein the protein equivalent comprises partially hydrolyzed protein having a degree of hydrolysis of less than 40%. 4. The nutritional composition of claim 1 , further comprising at least one long-chain polyunsaturated fatty acid. 5. The nutritional composition of claim 4 , wherein the at least one long-chain polyunsaturated fatty acid is selected from the group consisting of docosahexaenoic acid and arachidonic acid. 6. The nutritional composition of claim 1 , further comprising a culture supernatant from a late-exponential growth phase of a probiotic batch-cultivation process. 7. The nutritional composition of claim 1 , further comprising a probiotic. 8. The nutritional composition of claim 1 , further comprising a prebiotic. 9. A nutritional composition, comprising: (i) a carbohydrate; (ii) a fat; and (iii) a protein equivalent; wherein (a) at least 20% of the protein equivalent comprises a casein hydrolysate having a molar mass distribution of greater than 500 Daltons, and (b) at least 20% of the protein equivalent comprises a peptide component, wherein the peptide component consists of at least 5 individual peptides selected from the group consisting of SEQ ID NO 1, SEQ ID NO 2, SEQ ID NO 3, SEQ ID NO 5, SEQ ID NO 6, SEQ ID NO 7, SEQ ID NO 8, SEQ ID NO 9, SEQ ID NO 10, SEQ ID NO 11, SEQ ID NO 12, SEQ ID NO 14, SEQ ID NO 15, SEQ ID NO 16, SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 20, SEQ ID NO 22, SEQ ID NO 23, SEQ ID NO 25, SEQ ID NO 26, SEQ ID NO 27, SEQ ID NO 28, SEQ ID NO 29, SEQ ID NO 33, SEQ ID NO 34, SEQ ID NO 35, SEQ ID NO 36, SEQ ID NO 37, SEQ ID NO 38, SEQ ID NO 39, SEQ ID NO 40, SEQ ID NO 41, SEQ ID NO 42, SEQ ID NO 43, SEQ ID NO 44, SEQ ID NO 45, SEQ ID NO 46, SEQ ID NO 47, SEQ ID NO 48, SEQ ID NO 49, SEQ ID NO 50, SEQ ID NO 52, SEQ ID NO 53, SEQ ID NO 54, SEQ ID NO 55, SEQ ID NO 56, SEQ ID NO 58, SEQ ID NO 59, SEQ ID NO 61, SEQ ID NO 62, SEQ ID NO 64; and at least 3 individual peptides selected from SEQ ID NO 4, SEQ ID NO 13, SEQ ID NO 17, SEQ ID NO 21, SEQ ID NO 24, SEQ ID NO 30, SEQ ID NO 31, SEQ ID NO 32, SEQ ID NO 51, SEQ ID NO 57, SEQ ID NO 60, SEQ ID NO 63, wherein the peptide component is present in the nutritional composition in an amount of from about 0.2 g/100 kcals to about 5.6 g/100 kcals. 10. The nutritional composition of claim 9 , wherein the protein equivalent comprises partially hydrolyzed protein having a degree of hydrolysis of less than 40%. 11. The nutritional composition of claim 9 , further comprising a prebiotic. 12. The nutritional composition of claim 9 , further comprising a culture supernatant from a late-exponential growth phase of a probiotic batch-cultivation process. 13. The nutritional composition of claim 1 , wherein the nutritional composition further comprises intact protein. 14. The nutritional composition of claim 9 , wherein the nutritional composition further comprises intact protein. 15. The nutritional composition of claim 1 , comprising from about 1 g to about 7 g of protein equivalent per 100 kcal of nutritional composition. 16. The nutritional composition of claim 9 , comprising from about 1 g to about 7 g of protein equivalent per 100 kcal of nutritional composition. 17. The nutritional composition of claim 1 , comprising from about 5 g/100 kcal to about 25 g/100 kcal of a carbohydrate. 18. The nutritional composition of claim 9 , comprising from about 5 g/100 kcal to about 25 g/100 kcal of a carbohydrate.

Assignees

Inventors

Classifications

  • Bacteria or derivatives thereof, e.g. probiotics · CPC title

  • Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula · CPC title

  • Fatty acids or derivatives thereof · CPC title

  • Peptides; Protein hydrolysates · CPC title

  • A61K38/08Primary

    Peptides having 5 to 11 amino acids {(A61K38/043 - A61K38/046 take precedence)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9345741B2 cover?
The present disclosure relates to nutritional compositions including a protein equivalent source that includes a peptide component comprising selected peptides. The protein equivalent source may further include intact protein, hydrolyzed protein, including partially hydrolyzed protein, or combinations thereof. The disclosure further relates to methods of promoting healthy body weight in a targe…
Who is the assignee on this patent?
Mead Johnson Nutrition Co
What technology area does this patent fall under?
Primary CPC classification A61K38/08. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).